How to cite item

Erlotinib plus bevacizumab for EGFR-mutant advanced non-squamous non-small-cell lung cancer patients: ready for first-line?

   
@article{ATM30081,
	author = {Helen Adderley and Christoph Jakob Ackermann and Raffaele Califano},
	title = {Erlotinib plus bevacizumab for  EGFR -mutant advanced non-squamous non-small-cell lung cancer patients: ready for first-line?},
	journal = {Annals of Translational Medicine},
	volume = {7},
	number = {Suppl 8},
	year = {2019},
	keywords = {},
	abstract = {EGFR tyrosine kinase inhibitors (TKIs) represent the standard of care for first-line treatment for patients with advanced EGFR mutant non-small cell lung cancer (NSCLC) with superiority in overall response rate (ORR), progression free survival (PFS) and quality of life compared to platinum-based chemotherapy (ChT) (1).},
	issn = {2305-5847},	url = {https://atm.amegroups.org/article/view/30081}
}